13F-HR/A filed by PERCEPTIVE ADVISORS LLC
PERCEPTIVE ADVISORS LLC filed this 13F-HR/A for the quarter ended 2021-09-30, filed 2021-12-03, with 140 holding rows worth $6,884,438,000.
- Accession
- 0001012975-21-000492
- Filer
- CIK 1224962
- Filed
- 2021-12-03
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2021
A holdings report, amendment of type restatement, 139 entries on the cover page, a total value of $6,884,438,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $6,884,438,000 with VALUE read as thousands by filing date, 13F file number 028-10438. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 3,387,745 | $599,326,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 761299AB2 | NOTE 2.500% 9/1 | 45,000,000 | $454,824,000 | thousands by filing date | principal |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 7,756,928 | $363,567,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 4,849,912 | $307,678,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 11,489,772 | $283,337,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 26,559,443 | $253,643,000 | thousands by filing date | |
| LANDOS BIOPHARMA INC | 515069102 | CMN | 14,869,915 | $217,101,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 1,956,940 | $214,363,000 | thousands by filing date | |
| COLLEGIUM PHARMACEUTICAL INC | 19459JAA2 | NOTE 2.625% 2/1 | 17,500,000 | $180,250,000 | thousands by filing date | principal |
| VBI VACCINES INC | 91822J103 | COM NEW | 55,042,465 | $171,182,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 5,086,727 | $150,058,000 | thousands by filing date | |
| NEVRO CORP | 64157FAC7 | NOTE 2.750% 4/0 | 9,000,000 | $126,234,000 | thousands by filing date | principal |
| IVERIC BIO INC | 46583P102 | COM | 7,471,798 | $121,342,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 4,407,399 | $112,300,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 3,923,741 | $111,551,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 3,679,845 | $106,863,000 | thousands by filing date | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 2,258,566 | $100,913,000 | thousands by filing date | |
| OUTSET MEDICAL INC | 690145107 | COM | 1,990,633 | $98,417,000 | thousands by filing date | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 6,948,277 | $91,578,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 2,907,565 | $90,280,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 9,903,879 | $86,956,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 3,963,517 | $83,432,000 | thousands by filing date | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 2,259,224 | $79,208,000 | thousands by filing date | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 3,314,032 | $78,576,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 4,779,387 | $76,805,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 2,360,139 | $73,636,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 2,310,261 | $69,054,000 | thousands by filing date | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 1,656,990 | $63,214,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,943,097 | $61,266,000 | thousands by filing date | |
| ICOSAVAX INC | 45114M109 | COM | 1,922,549 | $56,888,000 | thousands by filing date | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 8,911,151 | $54,714,000 | thousands by filing date | |
| KRONOS BIO INC | 50107A104 | COM | 2,421,142 | $50,747,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 887,340 | $50,259,000 | thousands by filing date | |
| COHERUS BIOSCIENCES INC | 19249HAB9 | BOND | 4,500,000 | $49,365,000 | thousands by filing date | principal |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 1,965,555 | $47,665,000 | thousands by filing date | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 537,635 | $46,780,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 483,007 | $46,325,000 | thousands by filing date | |
| VERRICA PHARMACEUTICALS INC | 92511W108 | COM | 3,610,412 | $45,130,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 2,148,060 | $44,980,000 | thousands by filing date | |
| KODIAK SCIENCES INC | 50015M109 | COM | 461,248 | $44,271,000 | thousands by filing date | |
| ATHENEX INC | 04685N103 | COM | 13,532,467 | $40,733,000 | thousands by filing date | |
| Veru Inc | 92536C103 | Common Stock | 4,451,342 | $37,970,000 | thousands by filing date | |
| RAIN ONCOLOGY INC | 75082Q105 | COM | 2,537,019 | $37,954,000 | thousands by filing date | |
| QUOTIENT LTD | G73268107 | SHS | 16,200,818 | $37,910,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 7,695,505 | $37,708,000 | thousands by filing date | |
| INHIBRX INC | 45720L107 | COM | 1,121,490 | $37,357,000 | thousands by filing date | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 505,541 | $36,186,000 | thousands by filing date | |
| SINGULAR GENOMICS SYSTEMS IN | 82933R100 | COM | 3,073,824 | $34,396,000 | thousands by filing date | |
| LEAP THERAPEUTICS INC | 52187K101 | COM | 8,476,496 | $33,990,000 | thousands by filing date | |
| TREACE MED CONCEPTS INC | 89455T109 | COM | 1,235,886 | $33,245,000 | thousands by filing date | |
| CAREMAX INC | 14171W103 | COM | 3,385,000 | $32,699,000 | thousands by filing date | |
| IMMATICS N.V | N44445109 | SHS | 2,500,000 | $32,500,000 | thousands by filing date | |
| ATHIRA PHARMA INC | 04746L104 | COM | 3,425,916 | $32,135,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 13,412,552 | $32,056,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 2,022,051 | $30,897,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 259,972 | $30,256,000 | thousands by filing date | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 3,041,004 | $30,228,000 | thousands by filing date | |
| HEALTH CATALYST INC | 42225T107 | COM | 589,004 | $29,456,000 | thousands by filing date | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 3,222,560 | $29,403,000 | thousands by filing date | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 1,296,416 | $27,937,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 3,188,750 | $26,817,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 141,700 | $26,155,000 | thousands by filing date | |
| SOMALOGIC INC | 83444K105 | COM | 2,050,000 | $25,400,000 | thousands by filing date | |
| BIOATLA INC | 09077B104 | COM | 850,026 | $25,025,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,423,000 | $23,408,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 885,818 | $21,818,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 393,613 | $21,251,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 615,000 | $20,270,000 | thousands by filing date | |
| SEMA4 HOLDINGS CORP | 81663L101 | COM | 2,500,000 | $18,975,000 | thousands by filing date | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 491,332 | $18,833,000 | thousands by filing date | |
| CUE HEALTH INC | 229790100 | COM | 1,580,607 | $18,667,000 | thousands by filing date | |
| IMMUNEERING CORP | 45254E107 | CLASS A COM | 681,051 | $18,082,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 160,000 | $17,830,000 | thousands by filing date | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 987,500 | $17,370,000 | thousands by filing date | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 1,959,652 | $17,323,000 | thousands by filing date | |
| ABSCI CORPORATION | 00091E109 | COM | 1,476,776 | $17,175,000 | thousands by filing date | |
| NUVALENT INC COM | 670703107 | Stock | 750,000 | $16,913,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 2,888,889 | $15,831,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 923,200 | $15,786,000 | thousands by filing date | call |
| AGILE THERAPEUTICS INC | 00847L100 | COM | 15,919,925 | $15,301,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 13,262,375 | $14,986,000 | thousands by filing date | |
| HEALTHCOR CATALIO ACQU CORP | G44125105 | CL A SHS | 1,500,000 | $14,850,000 | thousands by filing date | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 400,000 | $14,828,000 | thousands by filing date | |
| GRAPHITE BIO INC | 38870X104 | COM | 875,093 | $14,343,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 781,236 | $14,062,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 48,600 | $13,753,000 | thousands by filing date | |
| VIATRIS INC COM | 92556V106 | Stock | 1,004,419 | $13,610,000 | thousands by filing date | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 556,047 | $13,195,000 | thousands by filing date | |
| CM LIFE SCIENCES III INC | 125841205 | UNIT 04/30/2028 | 1,250,000 | $12,813,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009RAD1 | BOND | 1,000,000 | $12,799,000 | thousands by filing date | principal |
| INSULET CORP COM | 45784P101 | Stock | 44,522 | $12,654,000 | thousands by filing date | |
| NANOBIOTIX | 63009J107 | SPONSORED ADS | 1,059,800 | $12,039,000 | thousands by filing date | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 352,804 | $11,992,000 | thousands by filing date | |
| ACCOLADE INC | 00437E102 | COM | 279,774 | $11,798,000 | thousands by filing date | |
| ZYMERGEN INC | 98985X100 | COM | 883,332 | $11,633,000 | thousands by filing date | |
| CLOVER HEALTH INVESTMENTS CO | 18914F103 | COMMON STOCK | 1,500,000 | $11,085,000 | thousands by filing date | |
| 1LIFE HEALTHCARE INC | 68269G107 | COM | 532,350 | $10,780,000 | thousands by filing date | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 180,000 | $10,573,000 | thousands by filing date | |
| ONCORUS INC | 68236R103 | COM | 1,099,810 | $10,272,000 | thousands by filing date | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 375,256 | $10,121,000 | thousands by filing date | |
| SUMMIT HEALTHCRE ACQUISTN CO | G8566R128 | UNIT 06/03/2026 | 1,000,000 | $10,050,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 1,000,000 | $9,960,000 | thousands by filing date | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 1,254,607 | $9,936,000 | thousands by filing date | |
| RESEARCH ALLIANCE CORP II | 760873109 | CMN | 1,000,000 | $9,850,000 | thousands by filing date | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 1,242,879 | $9,557,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 550,000 | $9,405,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 301,714 | $8,991,000 | thousands by filing date | |
| SIGHT SCIENCES INC | 82657M105 | COMMON STOCK | 390,000 | $8,853,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 294,118 | $8,297,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 100,000 | $7,123,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 2,150,641 | $7,033,000 | thousands by filing date | |
| RAPID MICRO BIOSYSTEMS INC | 75340L104 | CLASS A COM | 350,000 | $6,465,000 | thousands by filing date | |
| FILANA THERAPEUTICS INC | 14817C107 | CMN | 100,000 | $6,208,000 | thousands by filing date | put |
| NEPTUNE WELLNESS SOLUTIONS I | 64079L105 | COM | 10,055,521 | $6,080,000 | thousands by filing date | |
| PROVENTION BIO INC | 74374N102 | COM | 948,481 | $6,070,000 | thousands by filing date | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 320,440 | $5,967,000 | thousands by filing date | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 755,375 | $5,884,000 | thousands by filing date | |
| POSEIDA THERAPEUTICS INC | 73730P108 | COM | 787,745 | $5,743,000 | thousands by filing date | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 430,900 | $5,252,000 | thousands by filing date | |
| DA32 LIFE SCNCE TEC ACQSTN C | 23312M106 | CLASS A COM | 500,000 | $4,915,000 | thousands by filing date | |
| CODEX DNA INC | 192003101 | COM | 425,000 | $4,730,000 | thousands by filing date | |
| DARIOHEALTH CORP | 23725P209 | COM | 327,869 | $4,475,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 450,000 | $4,451,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 89,283 | $3,743,000 | thousands by filing date | |
| Surrozen, Inc. | 86889P109 | COM | 500,000 | $3,540,000 | thousands by filing date | |
| VYNE THERAP. | 92941V209 | COM | 2,330,471 | $3,239,000 | thousands by filing date | |
| LIFESCI ACQUISITION II CORP | 53229E103 | COM | 300,000 | $2,940,000 | thousands by filing date | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 421,641 | $2,918,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 80,420 | $2,651,000 | thousands by filing date | |
| IMAGO BIOSCIENCES INC | 45250K107 | COM | 125,000 | $2,504,000 | thousands by filing date | |
| FREQUENCY THERAPEUTICS INC | 35803L108 | COM | 222,222 | $1,569,000 | thousands by filing date | |
| FERRARI N V | N3167Y103 | COM | 6,200 | $1,297,000 | thousands by filing date | |
| MOTUS GI HLDGS INC | 62014P108 | COM | 1,800,542 | $1,242,000 | thousands by filing date | |
| ROCKLEY PHOTONICS HLDGS LTD | G7614L117 | *W EXP 08/11/202 | 500,000 | $1,195,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 139,890 | $934,000 | thousands by filing date | |
| BUTTERFLY NETWORK INC | 124155110 | *W EXP 02/12/202 | 233,333 | $642,000 | thousands by filing date | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 27,000 | $479,000 | thousands by filing date | |
| SOMALOGIC INC | 83444k113 | WT | 110,000 | $380,000 | thousands by filing date | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 166,666 | $190,000 | thousands by filing date | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 60,000 | $170,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-21-000466 | superseded | 2021-11-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001012975-21-000492 | this filing | 2021-12-03 | acceptance time not in the bulk data set |